U.S. Radiology departments navigating CT market challenges—supply disruptions and rising demand for contrast and delivery—need reliable partners. Hear Bayer leads explain how Bayer helps provide steady supply and innovations to support CT imaging and patient care.
The Connecticut-based payer is labeling peripheral nerve stimulation, used to treat chronic pain, as medically unnecessary, with the Society of Interventional Radiology and others questioning the rationale.
Members of Congress caution that the fee could be especially consequential for rural and urban safety net hospitals, which could be pushed “to their financial brink” if they are required to absorb the charge.
Experts believe the imaging agent "has the potential to meaningfully advance early diagnosis, change the treatment paradigm and improve patient outcomes."
New data highlight the significant burden contrast media use places on the environment, prompting experts to call for more stringent use of these agents.
